Last updated: July 07, 2026

Application No. 18/683,426

Untitled Application

Unknown

Filed

1600

Priority

Aug 13, 2021 — provisional 63/232,922 +1 more

Examiner

YAMASAKI, ROBERT J

Art Unit

1653

Tech Center

Anagram Therapeutics, Inc.

Assignee

Anagram Therapeutics, Inc.

OA Round

1 (Non-Final)

Interview Optional

— +42.7% interview lift. Examiner has a relatively high allowance rate (68%); +42.7% interview lift. A written response may suffice.

Based on 552 resolved cases, 2023–2026

Examiner Intelligence

YAMASAKI, ROBERT J View full profile →

Grants 68% — above average

Career Allowance Rate

373 granted / 552 resolved

+7.6% vs TC avg

Strong +43% interview lift

Without

With

+42.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

36 currently pending

Career history

586

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

55.2%

+15.2% vs TC avg

§102

4.9%

-35.1% vs TC avg

§112

10.2%

-29.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 552 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/948,749

Patent 12660812

CRYOPROTECTING AGENT, CRYOPROTECTING AND CRYOPRESERVED COMPOSITIONS, USES THEREOF, AND METHODS OF CRYOPRESERVATION

3y 9m to grant Granted Jun 23, 2026

17/670,372

Patent 12649940

ENZYMATIC OLIGONUCLEOTIDE ASSEMBLY USING HAIRPINS AND ENZYMATIC CLEAVAGE

4y 3m to grant Granted Jun 09, 2026

18/776,537

Patent 12642273

METHODS OF PROTECTING A PLANT FROM A FUNGAL PEST

1y 10m to grant Granted Jun 02, 2026

18/602,073

Patent 12636324

METHOD OF PROMOTING FIRMNESS, ELASTICITY AND WOUND HEALING ABILITY OF THE VULVA AND THE VAGINA

2y 2m to grant Granted May 26, 2026

17/636,597

Patent 12624383

KINASE ACTIVITY SIGNATURES FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG CARCINOMA PATIENTS TO A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR

4y 2m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

68%

Grant Probability

99%

With Interview (+42.7%)

3y 3m

Median Time to Grant

Low

PTA Risk

Based on 552 resolved cases by this examiner. Grant probability derived from career allowance rate.